These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32398021)

  • 1. Endoplasmic reticulum retention and degradation of a mutation in SLC6A1 associated with epilepsy and autism.
    Wang J; Poliquin S; Mermer F; Eissman J; Delpire E; Wang J; Shen W; Cai K; Li BM; Li ZY; Xu D; Nwosu G; Flamm C; Liao WP; Shi YW; Kang JQ
    Mol Brain; 2020 May; 13(1):76. PubMed ID: 32398021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic mosaicism, intrafamilial phenotypic heterogeneity, and molecular defects of a novel missense SLC6A1 mutation associated with epilepsy and ADHD.
    Poliquin S; Hughes I; Shen W; Mermer F; Wang J; Mack T; Xu D; Kang JQ
    Exp Neurol; 2021 Aug; 342():113723. PubMed ID: 33961861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons.
    Mermer F; Poliquin S; Rigsby K; Rastogi A; Shen W; Romero-Morales A; Nwosu G; McGrath P; Demerast S; Aoto J; Bilousova G; Lal D; Gama V; Kang JQ
    Brain; 2021 Sep; 144(8):2499-2512. PubMed ID: 34028503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense mutation in SLC6A1 associated with Lennox-Gastaut syndrome impairs GABA transporter 1 protein trafficking and function.
    Cai K; Wang J; Eissman J; Wang J; Nwosu G; Shen W; Liang HC; Li XJ; Zhu HX; Yi YH; Song J; Xu D; Delpire E; Liao WP; Shi YW; Kang JQ
    Exp Neurol; 2019 Oct; 320():112973. PubMed ID: 31176687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic GABA transporter 1 deficit in novel SLC6A1 variants mediated epilepsy: Connected from protein destabilization to seizures in mice and humans.
    Mermer F; Poliquin S; Zhou S; Wang X; Ding Y; Yin F; Shen W; Wang J; Rigsby K; Xu D; Mack T; Nwosu G; Flamm C; Stein M; Kang JQ
    Neurobiol Dis; 2022 Oct; 172():105810. PubMed ID: 35840120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variants.
    Silva DB; Trinidad M; Ljungdahl A; Revalde JL; Berguig GY; Wallace W; Patrick CS; Bomba L; Arkin M; Dong S; Estrada K; Hutchinson K; LeBowitz JH; Schlessinger A; Johannesen KM; Møller RS; Giacomini KM; Froelich S; Sanders SJ; Wuster A
    Am J Hum Genet; 2024 Jun; 111(6):1222-1238. PubMed ID: 38781976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy.
    Ahring PK; Liao VWY; Gardella E; Johannesen KM; Krey I; Selmer KK; Stadheim BF; Davis H; Peinhardt C; Koko M; Coorg RK; Syrbe S; Bertsche A; Santiago-Sim T; Diemer T; Fenger CD; Platzer K; Eichler EE; Lerche H; Lemke JR; Chebib M; Møller RS
    Brain; 2022 May; 145(4):1299-1309. PubMed ID: 34633442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Aminobutyric acid transporter and GABA
    Shen W; Nwosu G; Honer M; Clasadonte J; Schmalzbauer S; Biven M; Langer K; Flamm C; Poliquin S; Mermer F; Dedeurwaerdere S; Hernandez MC; Kang JQ
    Brain Commun; 2024; 6(2):fcae110. PubMed ID: 38650830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC6A1 variants identified in epilepsy patients reduce γ-aminobutyric acid transport.
    Mattison KA; Butler KM; Inglis GAS; Dayan O; Boussidan H; Bhambhani V; Philbrook B; da Silva C; Alexander JJ; Kanner BI; Escayg A
    Epilepsia; 2018 Sep; 59(9):e135-e141. PubMed ID: 30132828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental phenotypes associated with pathogenic variants in
    Kahen A; Kavus H; Geltzeiler A; Kentros C; Taylor C; Brooks E; Green Snyder L; Chung W
    J Med Genet; 2022 Jun; 59(6):536-543. PubMed ID: 34006619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the phenotypic spectrum of SLC6A1 mutations.
    Johannesen KM; Gardella E; Linnankivi T; Courage C; de Saint Martin A; Lehesjoki AE; Mignot C; Afenjar A; Lesca G; Abi-Warde MT; Chelly J; Piton A; Merritt JL; Rodan LH; Tan WH; Bird LM; Nespeca M; Gleeson JG; Yoo Y; Choi M; Chae JH; Czapansky-Beilman D; Reichert SC; Pendziwiat M; Verhoeven JS; Schelhaas HJ; Devinsky O; Christensen J; Specchio N; Trivisano M; Weber YG; Nava C; Keren B; Doummar D; Schaefer E; Hopkins S; Dubbs H; Shaw JE; Pisani L; Myers CT; Tang S; Tang S; Pal DK; Millichap JJ; Carvill GL; Helbig KL; Mecarelli O; Striano P; Helbig I; Rubboli G; Mefford HC; Møller RS
    Epilepsia; 2018 Feb; 59(2):389-402. PubMed ID: 29315614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures.
    Carvill GL; McMahon JM; Schneider A; Zemel M; Myers CT; Saykally J; Nguyen J; Robbiano A; Zara F; Specchio N; Mecarelli O; Smith RL; Leventer RJ; Møller RS; Nikanorova M; Dimova P; Jordanova A; Petrou S; ; Helbig I; Striano P; Weckhuysen S; Berkovic SF; Scheffer IE; Mefford HC
    Am J Hum Genet; 2015 May; 96(5):808-15. PubMed ID: 25865495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived SLC6A1 variant S295L results in an epileptic phenotype similar to haploinsufficient mice.
    Lindquist BE; Voskobiynyk Y; Goodspeed K; Paz JT
    Epilepsia; 2023 Oct; 64(10):e214-e221. PubMed ID: 37501613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy.
    Tanaka M; Olsen RW; Medina MT; Schwartz E; Alonso ME; Duron RM; Castro-Ortega R; Martinez-Juarez IE; Pascual-Castroviejo I; Machado-Salas J; Silva R; Bailey JN; Bai D; Ochoa A; Jara-Prado A; Pineda G; Macdonald RL; Delgado-Escueta AV
    Am J Hum Genet; 2008 Jun; 82(6):1249-61. PubMed ID: 18514161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistency of parent-report SLC6A1 data in Simons Searchlight with Provider-Based Publications.
    Bain JM; Snyder LG; Helbig KL; Cooper DD; Chung WK; Goodspeed K
    J Neurodev Disord; 2022 Jun; 14(1):40. PubMed ID: 35761184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Clinical Repercussions of GABA Transporter 1 Variants Gone Amiss: Links to Epilepsy and Developmental Spectrum Disorders.
    Fischer FP; Kasture AS; Hummel T; Sucic S
    Front Mol Biosci; 2022; 9():834498. PubMed ID: 35295842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Phenylbutyrate restored γ-aminobutyric acid uptake and reduced seizures in
    Nwosu G; Mermer F; Flamm C; Poliquin S; Shen W; Rigsby K; Kang JQ
    Brain Commun; 2022; 4(3):fcac144. PubMed ID: 35911425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Phenylbutyrate promoted wild-type γ-aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2
    Shen W; Flamm C; Delahanty AJ; Casteel E; Biven M; DeLeeuw MB; Poliquin S; Nwosu G; Randhave K; Kang JQ
    Epilepsia; 2024 Jan; 65(1):204-217. PubMed ID: 37746768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission.
    Platzer K; Sticht H; Bupp C; Ganapathi M; Pereira EM; Le Guyader G; Bilan F; Henderson LB; Lemke JR; Taschenberger H; Brose N; Abou Jamra R; Wojcik SM
    Ann Neurol; 2022 Dec; 92(6):958-973. PubMed ID: 36073542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cortical GABAA receptor composition, physiology, and endocytosis in a mouse model of a human genetic absence epilepsy syndrome.
    Zhou C; Huang Z; Ding L; Deel ME; Arain FM; Murray CR; Patel RS; Flanagan CD; Gallagher MJ
    J Biol Chem; 2013 Jul; 288(29):21458-21472. PubMed ID: 23744069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.